Document is current
Any future updates will be listed below
-
Authors
Hou, Tsung-Wei
Tzeng, Yi-Shiang
Chen, Shih-Pin
Ling, Yu-Hsiang
Chen, Wei-Ta
Wang, Shuu-Jiun
Wang, Yen-Feng
-
Funding
Funding for this research was provided by:
National Science and Technology Council, Taiwan (110-2321-B-010-005；111-2321-B-A49-004；111-2314-B-075-086-MY3；111-2321-B-A49-011；112-2321-B-075-007)
Ministry of Health and Welfare, Taiwan (MOHW112-TDU-B-211-144001)
Taipei Veterans General Hospital (V108C-092；V109C-096；V110C-111；V111C-161；V112C-078；V113C-123；V114C-096；V112D67-003-MY3)
- License Information
-
More Information
Article History
Received: 27 November 2025
Accepted: 6 January 2026
First Online: 15 January 2026
Declarations
:
: This study was approved by the Institutional Review Boards of Taipei Veterans General Hospital (No. 2025-02-006AC) and Taipei Municipal Gan-Dau Hospital (No. 11403). Informed consent was waived due to the retrospective nature of the study.
: Not applicable.
: W.-T.C. has received honoraria as a speaker from Allergan/AbbVie, Hava Bio-Pharma, Orient EuroPharma, Pfizer, and Viatris. He has received research grants from the Taiwan National Science and Technology Council, and Taipei Veterans General Hospital. S.-J.W. has received personal fees as an advisor or speaker from Allergan/AbbVie, Orient EuroPharma, Pfizer, and Percept; and has been the PI in trials sponsored by Allergan/AbbVie, Lundbeck, Novartis, Pfizer, and Orient EuroPharma. He has received research grants from the Taiwan National Science and Technology Council and Taipei Veterans General Hospital. Y.-F.W. has received personal fees as an advisor or a speaker from Allergan/AbbVie, Boehringer Ingelheim, Chugai, Daiichi-Sankyo, Eli Lilly, Hava Bio-Pharma, Lundbeck, Novartis, Orient EuroPharma, Pfizer, Sanofi, Teva, UCB, and Viatris. He has received research grants from the Taiwan National Science and Technology Council, and Taipei Veterans General Hospital. T.-W.H., Y.-S.T., S.-P.C., and Y.-H.L. reported no relevant disclosure.
